Grants and Contributions:
Title:
515742
Agreement Number:
515742
Agreement Value:
$21,928,275.00
Agreement Date:
Jan 13, 2026 - Apr 30, 2030
Description:
API intends to perform the end to end manufacturing of antimicrobial drug products as a demonstration of domestic medicine manufacturing capabilities.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
Advance Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
Location:
Edmonton, Alberta, CA T5J 4P6
Reference Number:
033-2025-2026-Q4-515742
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
723985719
Recipient Type:
For-profit organization
Additional Information:
2025/26 to 2030/31,
Recipient's Operating Name:
Applied Pharmaceutical Innovation, API
Recipient's Legal Name:
Applied Pharmaceutical Innovation
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Life Sciences Fund Contributions
Program Purpose:
Misson-driven fund with a dual mandate to advance and strengthen Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
NAICS Code:
621510